Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

S Cano; S Cleanthous; P Marquis; J Hobart; S Naoshy; D Mikol; J Petrillo; D Steiner; C Watson

doi:10.1016/j.jval.2015.09.2688

Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

S Cano, S Cleanthous, P Marquis, J Hobart, S Naoshy, D Mikol, J Petrillo, D Steiner, C Watson

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	A713-A713
Number of pages	0
Journal	Value in Health
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2015.09.2688
Publication status	Published - Nov 2015

Access to Document

10.1016/j.jval.2015.09.2688

Cite this

@article{16b8c8eb305b4e5fa540a4c79fa8d944,

title = "Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36",

author = "S Cano and S Cleanthous and P Marquis and J Hobart and S Naoshy and D Mikol and J Petrillo and D Steiner and C Watson",

year = "2015",

month = nov,

doi = "10.1016/j.jval.2015.09.2688",

language = "English",

volume = "18",

pages = "A713--A713",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

AU - Cano, S

AU - Cleanthous, S

AU - Marquis, P

AU - Hobart, J

AU - Naoshy, S

AU - Mikol, D

AU - Petrillo, J

AU - Steiner, D

AU - Watson, C

PY - 2015/11

Y1 - 2015/11

U2 - 10.1016/j.jval.2015.09.2688

DO - 10.1016/j.jval.2015.09.2688

M3 - Article

SN - 1098-3015

VL - 18

SP - A713-A713

JO - Value in Health

JF - Value in Health

IS - 7

ER -